Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe ...

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo ...

The oversubscribed private financing round, with primary participation from Fidelity Management & Research Company, The Column Group, ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS) platform ...

UFO.create(FO, "ufoDemo"); 1 There are also consistent reductions in the size of the medial temporal lobe and the left neocortical superior temporal gyrus in patients with schizophrenia; those areas ...